Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have identified a link between inherited and acquired genetic factors that dramatically increase the chance of developing a very common type of melanoma. This finding appears in an online version of Science* on June 29, 2006, and was a collaborative effort […]

Results* of the Study of Tamoxifen and Raloxifene, or STAR, show that the drug raloxifene, currently used to prevent and treat osteoporosis in postmenopausal women, works as well as tamoxifen in reducing breast cancer risk for postmenopausal women at increased risk of the disease. In STAR, both drugs reduced the risk of developing invasive breast […]

Collaborative science at NCI led to invention of technology for HPV vaccine
Nearly two decades ago, researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and other institutions began searching for the underlying causes of cervical cancer. That scientific quest led to today’s approval by the Food and Drug Administration of […]

Gene expression profiling, a molecular technique that analyzes many genes simultaneously, can accurately distinguish between two types of immune cell tumors — Burkitt’s lymphoma and diffuse large B-cell lymphoma (DLBCL) — according to a team of researchers*, including several from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). Burkitt’s lymphoma […]